Drug survival of interleukin 17 inhibitors after switch from interleukin 23 inhibitors in psoriasis: An observational cohort study

被引：0
|
作者：
Kushnir-Grinbaum, Daniella [1 ,2 ]
Ziv, Michael [1 ]
机构：
[1] Techn Inst Technol, Rappaport Fac Med, Emek Med Ctr, Dermatol Dept, Afula, Israel
[2] Sinclair Dermatol, East Melbourne, Vic, Australia
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2024年 / 91卷 / 06期
关键词：
anti IL-17; anti IL-23; bio experienced; biologics; drug survival; guselkumab; IL-17; inhibitor; IL-23; interleukin-17;
D O I：
10.1016/j.jaad.2024.07.1514
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：1260 / 1263
页数：4
相关论文
共 50 条
  • [1] Drug Survival of Interleukin (IL)‑17 and IL‑23 Inhibitors for the Treatment of Psoriasis: A Retrospective Multi‑country, Multicentric Cohort Study
    Tiago Torres
    Luis Puig
    Ron Vender
    Jensen Yeung
    José-Manuel Carrascosa
    Stefano Piaserico
    Paolo Gisondi
    Charles Lynde
    Paulo Ferreira
    Pedro Mendes Bastos
    Esteban Dauden
    Luiz Leite
    Joana Valerio
    Elena del Alcázar-Viladomiu
    Eva Vilarrasa Rull
    Mar Llamas-Velasco
    Federico Pirro
    Francesco Messina
    Manfredo Bruni
    Gaetano Licata
    Federica Ricceri
    Alessia Nidegger
    Jan Hugo
    Asfandyar Mufti
    Athina-Ioanna Daponte
    Laetitia Teixeira
    Anna Balato
    Marco Romanelli
    Francesca Prignano
    Spyridon Gkalpakiotis
    Curdin Conrad
    Elizabeth Lazaridou
    Natalia Rompoti
    Marina Papoutsaki
    Miguel Nogueira
    Andrea Chiricozzi
    American Journal of Clinical Dermatology, 2022, 23 : 891 - 904
  • [2] The cardiometabolic safety of interleukin 23 versus interleukin 17 inhibitors in psoriasis: A large-scale global cohort study
    Kridin, Khalaf
    Mruwat, Noor
    Thaci, Diamant
    Ludwig, Ralf J.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2023, 37 (05) : E683 - E685
  • [3] Drug Survival of Interleukin (IL)-17 and IL-23 Inhibitors for the Treatment of Psoriasis: A Retrospective Multi-country, Multicentric Cohort Study
    Torres, Tiago
    Puig, Luis
    Vender, Ron
    Yeung, Jensen
    Carrascosa, Jose-Manuel
    Piaserico, Stefano
    Gisondi, Paolo
    Lynde, Charles
    Ferreira, Paulo
    Bastos, Pedro Mendes
    Dauden, Esteban
    Leite, Luiz
    Valerio, Joana
    del Alcazar-Viladomiu, Elena
    Rull, Eva Vilarrasa
    Llamas-Velasco, Mar
    Pirro, Federico
    Messina, Francesco
    Bruni, Manfredo
    Licata, Gaetano
    Ricceri, Federica
    Nidegger, Alessia
    Hugo, Jan
    Mufti, Asfandyar
    Daponte, Athina-Ioanna
    Teixeira, Laetitia
    Balato, Anna
    Romanelli, Marco
    Prignano, Francesca
    Gkalpakiotis, Spyridon
    Conrad, Curdin
    Lazaridou, Elizabeth
    Rompoti, Natalia
    Papoutsaki, Marina
    Nogueira, Miguel
    Chiricozzi, Andrea
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2022, 23 (06) : 891 - 904
  • [4] Interleukin-17 vs. Interleukin-23 Inhibitors in Pustular and Erythrodermic Psoriasis: A Retrospective, Multicentre Cohort Study
    Avallone, Gianluca
    Maronese, Carlo Alberto
    Murgia, Giulia
    Carrera, Carlo Giovanni
    Mastorino, Luca
    Roccuzzo, Gabriele
    Dapavo, Paolo
    Alberti-Violetti, Silvia
    Quaglino, Pietro
    Ribero, Simone
    Marzano, Angelo Valerio
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (04)
  • [5] COMPARISON OF THE DRUG SURVIVAL OF INTERLEUKIN (IL)-17 AND IL-23 INHIBITORS FOR THE TREATMENT OF PSORIASIS: A TWO-CENTER STUDY
    Kang, Kyong-Won
    Kang, Da-Hyun
    Kwon, Soon-Hyo
    Lew, Bark-Lynn
    Shin, Min Kyung
    Jeong, Ki-Heon
    ACTA DERMATO-VENEREOLOGICA, 2024, 104
  • [6] Do interleukin-17 and interleukin-23 inhibitors alter the coagulation parameters in psoriasis patients?: A retrospective study
    Unal, Simge
    Yuksek, Tugcan
    Ogut, Neslihan Demirel
    Yildirim, Sema Koc
    Erbagci, Ece
    Gokyayla, Ece
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 2024, 316 (08)
  • [7] Systematic review on rapidity of onset of action for interleukin-17 and interleukin-23 inhibitors for psoriasis
    Egeberg, A.
    Andersen, Y. M. F.
    Halling-Overgaard, A-S
    Alignahi, F.
    Thyssen, J. P.
    Burge, R.
    Mallbris, L.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2020, 34 (01) : 39 - 46
  • [8] Perceived quality of life in patients with psoriasis treated with interleukin 17 and 23 inhibitors
    Anguita-Montenegro, Barbara
    Areas-del Aguila, Vera Lucia
    Palacios-Moya, Elena
    Garcia-Arpa, Monica
    Sanchez-Caminero, Maria Prado
    Luque-Jimenez, Maria
    FARMACIA HOSPITALARIA, 2024, 48 (05) : 204 - 211
  • [9] Perceived quality of life in patients with psoriasis treated with interleukin 17 or 23 inhibitors
    Anguita-Montenegro, Barbara
    Aguila, Vera Lucia Areas-del
    Palacios-Moya, Elena
    Garcia-Arpa, Monica
    Sanchez-Caminero, Maria Prado
    Luque-Jimenez, Maria
    FARMACIA HOSPITALARIA, 2024, 48 (05) : T204 - T211
  • [10] Interleukin 23 inhibitors for psoriasis: not just another number
    Bachelez, Herve
    LANCET, 2017, 390 (10091): : 208 - 210
12345